MedPath

Thymon, LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2011-04-14
Last Posted Date
2013-02-15
Lead Sponsor
Thymon, LLC
Target Recruit Count
27
Registration Number
NCT01335191
Locations
🇺🇸

Clinilabs, New York, New York, United States

Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2010-06-15
Last Posted Date
2013-01-18
Lead Sponsor
Thymon, LLC
Target Recruit Count
15
Registration Number
NCT01144026
Locations
🇺🇸

Clinilabs, New York, New York, United States

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2009-02-20
Last Posted Date
2011-02-24
Lead Sponsor
Thymon, LLC
Target Recruit Count
24
Registration Number
NCT00848211
Locations
🇺🇸

Conant Medical Clinical Research, San Francisco, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.